Reproductive Health Drugs Advisory Committee
- Briefing Information for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee1
- J & J Briefing Information for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee (PDF – 12.31MB)2 (PDF - 12MB)
- FDA Briefing Information for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee (PDF – 1.75MB)3 (PDF - 5.6MB)
- Drug Safety and Risk Management Advisory Committee Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee4 (PDF - 32KB)
- Advisory Committee for Reproductive Health Drugs Committee Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee5 (PDF - 25KB)
- Draft Meeting Roster for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee6 (PDF - 62KB)
- Draft Questions for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee7 (PDF - 73KB)
- Draft Agenda for the December 9, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee8 (PDF - 89KB)
Circulatory System Devices Panel
- Transcript 10/13/119 (PDF - 1.1MB)
- 2011 Meeting Materials of the Circulatory System Devices Panel - continued10
- Panel Questions 12/8/1111 (PDF - 107KB)
- Agebda: Dec. 8, 201112 (PDF - 35KB)
- Sponsor Executive Summary13 (PDF - 221KB)
Reproductive Health Drugs Advisory Committee
Drug Safety and Risk Management Advisory Committee
Reproductive Health Drugs Advisory Committee
- Briefing Information for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee16
- Bayer Briefing Information for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee (PDF – 2.80MB)17 (PDF - 2.7MB)
- Drug Safety and Risk Management Advisory Committee Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee18 (PDF - 32KB)
- Advisory Committee for Reproductive Health Drugs Committee Roster for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee19 (PDF - 25KB)
- Draft Questions for the December 8, 2011 Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee20 (PDF - 37KB)
- 2011 Meeting Materials, Reproductive Health Drugs Advisory Committee21
Recently Updated Advisory Committee Materials
No hay comentarios:
Publicar un comentario